首页 | 本学科首页   官方微博 | 高级检索  
     

子宫内膜癌组织中垂体肿瘤转化基因PTTG的表达及其意义
引用本文:Wang YK,Cui N,Li J,Luo B. 子宫内膜癌组织中垂体肿瘤转化基因PTTG的表达及其意义[J]. 中华妇产科杂志, 2004, 39(8): 538-542,i002
作者姓名:Wang YK  Cui N  Li J  Luo B
作者单位:1. 266003,青岛大学医学院附属医院妇科
2. 266003,青岛大学医学院附属医院微生物教研室
摘    要:目的 检测子宫内膜癌组织中垂体肿瘤转化基因PTTG的表达,并分析其与碱性成纤维细胞生长因子(bFGF)蛋白表达和微血管密度(MVD)计数的相关性,探讨其在子宫内膜癌发生、发展中的作用。方法 采用RT-PCR技术,检测50例子宫内膜癌组织中PTTG mRNA的表达,并进行半定量分析;应用免疫组化链霉菌抗生物素蛋白-过氧化酶连接(SP)法,检测PTTG和bFGF蛋白的表达,CD34标记血管内皮细胞并计数肿瘤间质MVD;结合临床病理特征、bFGF蛋白及MVD计数进行分析。另选择15例增生性子宫内膜和12例正常子宫内膜组织作为对照。结果 子宫内膜癌组织中PTTG基因呈过度表达,内膜癌组织中PTTG mRNA的阳性表达率及平均表达水平(分别为96%,0.84±0.08)显著高于增生性子宫内膜(分别为60%,0.78±0.06)及正常子宫内膜组织(分别为33%,0.48±0.12),3组间分别比较,差异均有极显著性(P<0.01);内膜癌组织中PTTG蛋白的阳性表达率(70%)明显高于增生性子宫内膜(40%)及正常子宫内膜组织(17%),3组间分别比较,差异也均有极显著性(P<0.01);PTTG基因的表达与手术病理分期、淋巴结转移及肌层浸润有明显相关性(P<0.05),且其在子宫内膜样腺癌组织中的表达显著高于其他类型的内膜癌组织(P<0.05);PTTG基因的表达与年龄及病理分级无关(P>0.05)。子宫内膜癌组织

关 键 词:癌组织中 表达 子宫内膜癌 PTTG基因 bFGF蛋白 MVD 增生性 子宫内膜组织 RNA 标本

Expression of pituitary tumor-transforming gene in endometrial carcinoma
Wang Yan-kui,Cui Na,Li Jun,Luo Bing. Expression of pituitary tumor-transforming gene in endometrial carcinoma[J]. Chinese Journal of Obstetrics and Gynecology, 2004, 39(8): 538-542,i002
Authors:Wang Yan-kui  Cui Na  Li Jun  Luo Bing
Affiliation:Department of Gynecology, Affiliated Hospital of Medical College of Qingdao University, Qingdao 266003, China.
Abstract:OBJECTIVE: To study the expression of pituitary tumor-transforming gene (PTTG) and its relationship with the expression of basic fibroblast growth factor (bFGF) protein and microvessel density (MVD) in endometrial carcinoma. METHODS: Expressions of PTTG mRNA and protein were assessed by semi-quantitive RT-PCR and immunohistochemistry methods respectively in 50 cases of endometrial carcinomas, 15 cases of hyperplasia endometria and 12 cases of normal endometrial tissue. Expressions of bFGF protein were detected by immunohistochemistry. Microvessels were highlighted by staining endothelial cells with CD(34) antigen, and MVDs were counted. RESULTS: The expression rate and average quantity of PTTG mRNA were detected in a significantly greater proportion endometrial carcinomas (96%, 0.84 +/- 0.08) than in hyperplasia endometria (60%, 0.78 +/- 0.06) and normal endometrial tissue (33%, 0.48 +/- 0.12, P < 0.01, respectively). The expression of PTTG protein in endometrial carcinomas (70%) was significantly higher than in hyperplasia endometria (40%) and normal endometrial tissue (17%, P < 0.01). The expression of PTTG was related to surgical-pathological stage, myometrial infiltration depth, lymphatic metastasis and pathological subtype (P < 0.05, respectively), but was irrelevant to patients' age and pathological grade (P > 0.05, respectively). The average quantity of PTTG mRNA and expression rate of PTTG protein in tissues with bFGF protein coexpression (0.86 +/- 0.07, 87%) were higher than in those without bFGF protein coexpression (0.80 +/- 0.06, 42%, P < 0.01, respectively). The MVD in tissues with PTTG protein expression (62 +/- 18) was higher than in those without PTTG protein expression (51 +/- 12, P < 0.05). CONCLUSIONS: PTTG may play an important role in carcinogenesis and development of endometrial carcinoma. PTTG induces an angiogenesis through bFGF which is a key determinant step in tumor progression and metastatic spread.
Keywords:Neoplasm proteins  Endometrial neoplasms  Fibroblast growth factor 2  Neovascularization   pathologic  Immunohistochemistry  Semi-quantitive reverse  Polymerase chain reaction
本文献已被 CNKI 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号